Travere (TVTX) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Travere Therapeutics (TVTX) reported $62.9 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 69.5%. EPS of -$0.70 for the same period compares to -$1.17 a year ago.The reported revenue represents a surprise of +4.10% over the Zacks Consensus Estimate of $60.42 million. With the consensus EPS estimate being -$0.70, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ...